Immediate Impact
1 from Science/Nature 52 standout
Citing Papers
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
2023 Standout
Surgical Site Infection Prevention
2023 Standout
Works of Thomas D. Maher being referenced
Effect of Glucagon-Like Peptide-1 (GLP-1) on Glycemic Control and Left Ventricular Function in Patients Undergoing Coronary Artery Bypass Grafting
2007
Recent experience with major sternal wound complications
1990
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Thomas D. Maher | 568 | 334 | 290 | 29 | 913 | |
| Bengt Ullman | 319 | 443 | 246 | 21 | 958 | |
| Marco R. DiTullio | 405 | 422 | 318 | 18 | 922 | |
| Nozomu Oda | 274 | 345 | 184 | 41 | 821 | |
| Chris J. Kapelios | 284 | 486 | 210 | 66 | 829 | |
| A Barankay | 658 | 318 | 209 | 41 | 1.0k | |
| Brent C. Lampert | 429 | 377 | 364 | 47 | 779 | |
| Kazuoki Dai | 364 | 463 | 194 | 51 | 813 | |
| Francesco Clemenza | 393 | 746 | 279 | 62 | 1.1k | |
| G. Marrone | 475 | 127 | 69 | 23 | 825 | |
| Damian M. Craig | 332 | 234 | 139 | 52 | 1.0k |
All Works
Loading papers...